Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novartis Ag ADR
(NY:
NVS
)
99.04
+1.31 (+1.34%)
Streaming Delayed Price
Updated: 3:23 PM EDT, May 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novartis Ag ADR
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
September 15, 2023
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions.
Via
Investor's Business Daily
Exposures
Product Safety
Sandoz Pushes Product Launch Plans As Novartis Shareholders Approve The Spin-Off
September 15, 2023
At an Extraordinary General Meeting, Novartis AG's (NYSE: NVS) shareholders
Via
Benzinga
2 Dividend Stocks to Buy and Hold Forever
September 13, 2023
These companies' prospects look secure.
Via
The Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug discovery to patient care....
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Qualcomm-Apple's Chip Supply Agreement, Alleged Report About AstraZeneca CEO Sir Pascal Soriot's Intention To Step Down, Apple & Google Face Off in Antitrust Showdown: Today's Top Stories
September 11, 2023
Benzinga Qualcomm Announces Chip Supply Agreement With Apple
Via
Benzinga
Price Over Earnings Overview: Novartis
September 01, 2023
Via
Benzinga
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
September 11, 2023
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has
Via
Benzinga
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
September 05, 2023
Novartis expects to submit regulatory applications for its biosimilar soon.
Via
The Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?
Via
The Motley Fool
Biden Administration Vs. Big Pharma: What the Legal Showdown Means for Your Wallet
August 31, 2023
The Biden administration's move to lower drug prices has prompted a flurry of legal challenges.
Via
Benzinga
Peering Into Novartis's Recent Short Interest
August 31, 2023
Via
Benzinga
2 Excellent Stocks to Buy and Hold Forever
August 17, 2023
These companies have solid long-term potential.
Via
The Motley Fool
2 Top Biotech Stocks to Buy Right Now
August 14, 2023
These drugmakers are among the most dominant in the world.
Via
The Motley Fool
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
August 29, 2023
Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.
Via
The Motley Fool
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle
August 29, 2023
The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including:
Via
Benzinga
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts
August 29, 2023
The Biden administration is planning to negotiate the prices of 10 drugs in 2026.
Via
Investor's Business Daily
3 AI Stocks With the Potential to Transform Your Financial Future
August 28, 2023
Are you looking to invest in AI stocks? Here are three picks with the potential to transform your financial future.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Emerging Market Stocks to Buy in August
August 28, 2023
These three emerging market stocks to buy in August will have very strong, positive catalysts going forward.
Via
InvestorPlace
Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest
August 24, 2023
Thursday, Exelixis Inc (NASDAQ: EXEL) announced that the Alliance for Clinical Trials in Oncology independent Data and Safety Monitoring Board (DSMB) unanimously recommended to unblind and stop the...
Via
Benzinga
Cheaper Version Of Blockbuster Arthritis Treatment Humira - CVS Health Teams With Sandoz
August 24, 2023
CVS Health Corp (NYSE: CVS) has launched Cordavis, a wholly-owned subsidiary, to work directly with manufacturers to commercialize and/or co-produce biosimilar
Via
Benzinga
Could This Medicine Be the Next Winner for Novartis?
August 23, 2023
The Swiss drugmaker recently reported that a drug candidate met the primary endpoints in phase 3 clinical trials.
Via
The Motley Fool
Gold Rush In Weight Loss Industry Impacts Retailers With Pharmacy Businesses
August 22, 2023
Retailers with pharmacy businesses, including major players like Walmart Inc (NYSE: WMT), Kroger Company (NYSE: KR), and Rite Aid Corp (NYSE:
Via
Benzinga
Why This Regeneron Approval 'Could Not Come Soon Enough' As Novartis Looms
August 21, 2023
The FDA signed off on Regeneron's high-dose Eylea about two months earlier than expected.
Via
Investor's Business Daily
Exposures
Product Safety
SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories
August 18, 2023
Benzinga
Via
Benzinga
Merck Reveals Mixed Results From Pivotal Kidney Cancer Study Of Welireg In Pretreated Patients
August 18, 2023
Merck & Co Inc (NYSE: MRK) released topline results from LITESPARK-005, a Phase 3 trial investigating WELIREG (belzutifan), Merck's oral hypoxia-inducible
Via
Benzinga
Novartis' Generic Business Spinoff: Plans Sandoz Spin-Off In Early October, Proposes Share Distribution
August 18, 2023
Novartis AG (NYSE: NVS)
Via
Benzinga
3 Unstoppable Dividend Stocks to Buy Right Now
August 12, 2023
These stocks' dividends are more dependable than most.
Via
The Motley Fool
Novartis's Remibrutinib Shows Rapid Improvement In Type Of Skin Disorder That Impacts 40M People
August 09, 2023
Novartis AG (NYSE: NVS)
Via
Benzinga
The Year’s Top 3 International ETFs as of August 2023
August 07, 2023
By investing in international ETFs, you can mitigate potential losses with a more diversified portfolio. Here are three with strong returns.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.